Thanks golfyeti & masila.
I would think even if the treatment results were poor for the virus, there would still be potential for post-viral long covid effects.
Seems to me that Don had also hinted that the Phase 2 data, as far as it got, was actually not bad either. Though he may have just been saying that the trials were halted purely for slow enrollment vs. any data consideration. Would have to give that last talk another listen.
Wonder whether articles like this could affect our ability to get enrollment, though?
